Skip To Content
JEWISH. INDEPENDENT. NONPROFIT.
Breaking News

Israel Sees Spike in Organ Donation

Israel had 117 kidney transplants from living donors over the past year, 64 percent more than in 2010, according to the National Transplant Center’s annual report. In August 2010 living donors began receiving compensation of several thousand shekels, which may have contributed to the increase.

Compensation to living donors covers 40 days of lost wages and monetary benefits of up to NIS 30,000 for proven expenses of up to five years. These include transportation costs, supplementary and private medical insurance, disability insurance, life insurance, five psychological treatment sessions, and a week-long convalescence vacation.

The “chain of living donors” program was also launched in Israel during 2011. The program enables relatives of Israelis waiting for a kidney transplant to be donors for others on the waiting list, in exchange for their own family member receiving a new kidney through the same network. This model is used in situations where no suitable match is found for transplant candidates among their own relatives.

Developed in Holland, the program was brought to Israel at the initiative of Prof. Francis Delmonico of Harvard University, president of the international Transplantation Society and a consultant to the World Health Organization on preventing organ trafficking.

Israel experienced a dramatic increase in the number of organ transplants in 2011, totaling 384, 68 percent higher than the previous year, although the number of transplants performed in 2010 was particularly low. Kidney transplants from deceased donors were 2.37 times greater in 2011, with 123 operations, than in 2010. There were 69 liver transplants from deceased donors in the past year, 2.15 times as many the previous year, 59 lung transplants, representing an 84 percent increase, and 23 heart transplants — 2.09 times the number in 2010.

Another milestone was reached in 2011 when the percentage of families consenting to organ donations in cases of brain death surpassed the 50 percent mark, reaching 55 percent — a total of 89 donors.

For more, go to haaretz.com

I hope you appreciated this article. Before you go, I’d like to ask you to please support the Forward’s award-winning, nonprofit journalism during this critical time.

Now more than ever, American Jews need independent news they can trust, with reporting driven by truth, not ideology. We serve you, not any ideological agenda.

At a time when other newsrooms are closing or cutting back, the Forward has removed its paywall and invested additional resources to report on the ground from Israel and around the U.S. on the impact of the war, rising antisemitism and the protests on college campuses.

Readers like you make it all possible. Support our work by becoming a Forward Member and connect with our journalism and your community.

Make a gift of any size and become a Forward member today. You’ll support our mission to tell the American Jewish story fully and fairly. 

— Rachel Fishman Feddersen, Publisher and CEO

Join our mission to tell the Jewish story fully and fairly.

Republish This Story

Please read before republishing

We’re happy to make this story available to republish for free, unless it originated with JTA, Haaretz or another publication (as indicated on the article) and as long as you follow our guidelines. You must credit the Forward, retain our pixel and preserve our canonical link in Google search.  See our full guidelines for more information, and this guide for detail about canonical URLs.

To republish, copy the HTML by clicking on the yellow button to the right; it includes our tracking pixel, all paragraph styles and hyperlinks, the author byline and credit to the Forward. It does not include images; to avoid copyright violations, you must add them manually, following our guidelines. Please email us at editorial@forward.com, subject line “republish,” with any questions or to let us know what stories you’re picking up.

We don't support Internet Explorer

Please use Chrome, Safari, Firefox, or Edge to view this site.

Exit mobile version